# Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity

> **NCT01652001** · PHASE2,PHASE3 · COMPLETED · sponsor: **Universidad de Granada** · enrollment: 185 (actual)

## Conditions studied

- Xerostomia
- Depression
- Hypertension

## Interventions

- **DRUG:** Malic Acid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01652001
- **Lead sponsor:** Universidad de Granada
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 185 (ACTUAL)
- **Last updated:** 2016-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01652001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01652001, "Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01652001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*